跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRO-ZOLPIDEM ODT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRO-ZOLPIDEM ODT
Authorized
STANDARD
PRO-ZOLPIDEM ODT
PRO DOC LIMITEE
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5089cb7e26cbc505
Company
PRO DOC LIMITEE
Type
Standard
Approval Details
Approval Id
5089cb7e26cbc505
Drug Approval Canada Name
PRO-ZOLPIDEM ODT
Product Name
PRO-ZOLPIDEM ODT
Status
Marketed
Status Date
2023-10-30
Original Market Date
2023-10-30
Din
02537354
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Sublingual
Schedule
Targeted (CDSA IV)
Ahfs
28:24.92
Atc Original
N05CF02 ZOLPIDEM
Atc Name
n 05 cf 02
Aig Number
0122857002
Company Name
PRO DOC LIMITEE
Company Address
2925 Boulevard Industriel, Laval, Quebec, Canada, H7L 3W9
Active Ingredients
ZOLPIDEM TARTRATE
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5089cb7e26cbc505
Type
Standard
Back to Health Canada Approvals